Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
UBS
Chinese Patent Office
Queensland Health
US Department of Justice
McKesson

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Elobixibat

« Back to Dashboard

US Patents for Elobixibat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Elobixibat ➤ Sign Up IBAT inhibitors for the treatment of liver diseases Albireo AB (Gothenburg, SE) ➤ Sign Up
Elobixibat ➤ Sign Up Benzothiazepine derivatives AstraZeneca AB (Sodertalje, SE) ➤ Sign Up
Elobixibat ➤ Sign Up Benzothiazepine derivatives AstraZeneca AB (Sodertalje, SE) ➤ Sign Up
Elobixibat ➤ Sign Up Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor .alpha.(PPAR) AstraZeneca AB (Sodertalje, SE) ➤ Sign Up
Elobixibat ➤ Sign Up 3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha AstraZeneca AB (Sodertalje, SE) ➤ Sign Up
Elobixibat ➤ Sign Up 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders AstraZeneca AB (Sodertalje, SE) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Elobixibat

Drugname Country Document Number Estimated Expiration Related US Patent
Elobixibat Australia 2011326871 2030-11-08 ➤ Sign Up
Elobixibat Brazil 112013010157 2030-11-08 ➤ Sign Up
Elobixibat Canada 2815749 2030-11-08 ➤ Sign Up
Elobixibat China 103260625 2030-11-08 ➤ Sign Up
Elobixibat China 105288580 2030-11-08 ➤ Sign Up
Elobixibat Cyprus 1118125 2030-11-08 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
US Department of Justice
Boehringer Ingelheim
Chubb
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.